Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan M Clary

Showing results (91-100 of 107) with videos related to

Pageof 11
Sort By:
Annals of Surgical Oncology|November 4, 2008
Timing of multimodality therapy for resectable synchronous colorectal liver metastases: a retrospective multi-institutional analysisSrinevas K Reddy, Daria Zorzi, Ying Wei Lum, et al.
Molecular Cancer Therapeutics|February 22, 2012
Characterization of an oxaliplatin sensitivity predictor in a preclinical murine model of colorectal cancerMickey K Kim, Takuya Osada, William T Barry, et al.
International Journal of Radiation Oncology, Biology, Physics|August 11, 2007
Duodenal adenocarcinoma: patterns of failure after resection and the role of chemoradiotherapyChris R Kelsey, John W Nelson, Christopher G Willett, et al.
Journal of the American College of Surgeons|March 20, 2012
Hepatectomy for noncolorectal non-neuroendocrine metastatic cancer: a multi-institutional analysisRyan T Groeschl, Ido Nachmany, Jennifer L Steel, et al.
Annals of Surgical Oncology|September 7, 2007
Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysisSrinevas K Reddy, Timothy M Pawlik, Daria Zorzi, et al.
Annals of Surgical Oncology|April 14, 2005
Significance of histological response to preoperative chemoradiotherapy for pancreatic cancerRebekah R White, H Bill Xie, Marcia R Gottfried, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2006
Increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer: phase I trial resultsBrian G Czito, Christopher G Willett, Johanna C Bendell, et al.
Cancer|March 15, 2012
The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 casesMechteld C de Jong, Hugo Marques, Bryan M Clary, et al.
JAMA Surgery|March 7, 2014
A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experienceOmar Hyder, Hugo Marques, Carlo Pulitano, et al.
Annals of Surgery|May 10, 2013
A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancerMichael A Morse, Donna Niedzwiecki, John L Marshall, et al.
Pageof 11

Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
Annals of Surgical Oncology|November 4, 2008
Timing of multimodality therapy for resectable synchronous colorectal liver metastases: a retrospective multi-institutional analysisSrinevas K Reddy, Daria Zorzi, Ying Wei Lum, et al.
Molecular Cancer Therapeutics|February 22, 2012
Characterization of an oxaliplatin sensitivity predictor in a preclinical murine model of colorectal cancerMickey K Kim, Takuya Osada, William T Barry, et al.
International Journal of Radiation Oncology, Biology, Physics|August 11, 2007
Duodenal adenocarcinoma: patterns of failure after resection and the role of chemoradiotherapyChris R Kelsey, John W Nelson, Christopher G Willett, et al.
Journal of the American College of Surgeons|March 20, 2012
Hepatectomy for noncolorectal non-neuroendocrine metastatic cancer: a multi-institutional analysisRyan T Groeschl, Ido Nachmany, Jennifer L Steel, et al.
Annals of Surgical Oncology|September 7, 2007
Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysisSrinevas K Reddy, Timothy M Pawlik, Daria Zorzi, et al.
Annals of Surgical Oncology|April 14, 2005
Significance of histological response to preoperative chemoradiotherapy for pancreatic cancerRebekah R White, H Bill Xie, Marcia R Gottfried, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2006
Increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer: phase I trial resultsBrian G Czito, Christopher G Willett, Johanna C Bendell, et al.
Cancer|March 15, 2012
The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 casesMechteld C de Jong, Hugo Marques, Bryan M Clary, et al.
JAMA Surgery|March 7, 2014
A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experienceOmar Hyder, Hugo Marques, Carlo Pulitano, et al.
Annals of Surgery|May 10, 2013
A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancerMichael A Morse, Donna Niedzwiecki, John L Marshall, et al.
Pageof 11